topleft
topright

Want This Page Wider?

Use the A+, A-, R, and <> or <-> buttons at the top right of this page to make the fonts bigger and smaller or switch between a fixed-width and fluid-width style to this web site.
U.S. Army Medicine Leads In Infectious Disease Research PDF Print E-mail
In 2004, U.S. Army Col. Jerome Kim, an infectious disease physician, flew to Bangkok to oversee a massive HIV vaccine study.

It was the opportunity of a lifetime-and the stakes were high. If successful, it could be the first vaccine to show even moderate protection against HIV infection—a  critical milestone in the fight against HIV.

Sponsored by the U.S. Army in partnership with the government of Thailand, the Phase III clinical trial known as RV144 followed 16,000 Thai volunteers. The results announced in 2009 "showed an efficacy rate of 31.2 percent in vaccine recipients," said Dr. Kim, now the Deputy Director of the U.S. Military HIV Research Program (MHRP) at the Walter Reed Army Institute of Research (WRAIR).

"This achievement paved the way for us to learn more about the HIV virus, refine the vaccine and boost the immune response so the next generation of the vaccines will be more effective," he said.
 
< Prev   Next >

West-Point.Org (WP-ORG), a 501(c)(3) non-profit organization not affiliated officially with the United States Military Academy, provides an online communications infrastructure that enables graduates, parents, and friends of the military academy to maintain and strengthen the associations that bind us together. We will provide this community any requested support, consistent with this purpose, as quickly and efficiently as possible. WP-ORG is funded by the generosity of member contributions. Our communication services are provided in cooperation with the AOG (independent of USMA) and are operated by volunteers serving the Long Gray Line. Contents of and comments on this web site do not reflect the official position of the United States Military Academy or the Department of the Army.  For questions or comments, please email us at This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

Joomla Template by Joomlashack
Joomla Templates by JoomlaShack Joomla Templates